Patent details

Basic Information

Publication number:

EP2402754

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP111728127

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Unstructured recombinant polymers and uses thereof

French Title of Invention:

Polymères recombinants non structurés et leurs utilisations

German Title of Invention:

Unstrukturierte rekombinante Polymere und Verwendungen davon

SPC Number:

Dates

Filing date:

06/03/2007

Grant date:

19/11/2014

EP Publication Date:

04/01/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/01/2012

EP B1 Publication Date:

19/11/2014

EP B2 Publication Date:

26/07/2023

EP B3 Publication Date:

Lapsed date:

Expiration date:

06/03/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/09/2023

 

 

Name:

AMUNIX PHARMACEUTICALS, INC.

Address:

2 Tower Place, 1100, 94080, South San Francisco, California , United States (US)

History of Owners

From:

19/07/2023

To:

05/09/2023

Name:

Amunix Operating Inc.

Address:

500 Ellis Street Suite B, Mountain View, CA 94043, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

24/12/2014

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Crameri, Andreas

Address:

United States (US)

2

Name:

Wang, Chia-wei

Address:

United States (US)

3

Name:

Scholle, Michael D.

Address:

United States (US)

4

Name:

Popkov, Mikhail

Address:

United States (US)

5

Name:

Gordon, Nathaniel C.

Address:

United States (US)

6

Name:

Stemmer, Willem P.

Address:

United States (US)

7

Name:

Schellenberger, Volker

Address:

United States (US)

Priority

1

Priority Number:

743410 P

Priority Date:

06/03/2006

Priority Country:

United States (US)

2

Priority Number:

743622 P

Priority Date:

21/03/2006

Priority Country:

United States (US)

3

Priority Number:

528950

Priority Date:

27/09/2006

Priority Country:

United States (US)

4

Priority Number:

528927

Priority Date:

27/09/2006

Priority Country:

United States (US)

Classification

IPC classification:

G01N 33/53; G01N 33/567; C12N 15/06;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2023/11

Publication date:

05/10/2023

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:

202330

Publication date:

26/07/2023

Description:

Patent maintained (B2 publication)

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20230000381A

Date Registered:

05/09/2023

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Change of name and address

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

AMUNIX PHARMACEUTICALS, INC.

Address:

2 Tower Place, 1100, 94080, South San Francisco, California , United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

27/02/2026

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
05/09/2023	Request For Change	1
08/09/2023	Outgoing Correspondence	1